Changes in the Use of Telephone Follow-ups among Patients with Urologic Malignancies in Japan
BACKGROUNDThis study aimed to compare telephone follow-ups for patients with urologic malignancies in Japan before and during the COVID-19 pandemic.METHODSUsing the database of the Japan Medical Data Center Co., Ltd., we identified patients with urologic malignancies who underwent at least one telep...
        Saved in:
      
    
          | Published in | Annals of Clinical Epidemiology Vol. 7; no. 3; pp. 80 - 89 | 
|---|---|
| Main Authors | , , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
        Japan
          Society for Clinical Epidemiology
    
        01.07.2025
     一般社団法人 日本臨床疫学会  | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 2434-4338 2434-4338  | 
| DOI | 10.37737/ace.25010 | 
Cover
| Abstract | BACKGROUNDThis study aimed to compare telephone follow-ups for patients with urologic malignancies in Japan before and during the COVID-19 pandemic.METHODSUsing the database of the Japan Medical Data Center Co., Ltd., we identified patients with urologic malignancies who underwent at least one telephone follow-up between April 2014 and March 2020.The self-controlled case series method was used to calculate the incidence rate ratio of telephone follow-up utilization for the pandemic using the pre-pandemic period as a reference.RESULTSOf the 289 patients, 31 were women. Their median age was 80 years, and the median observation period was 28 months.The incidence rate ratio for telephone follow-up utilization during the pandemic was 17.8 compared to that of the pre-pandemic period. In an analysis stratified by type of carcinoma, the incidence rate ratios were higher in all strata than they were before the pandemic. However, among male patients with genital malignancies, particularly prostate cancers, the incidence rate ratio was lower than in other strata.According to analysis stratified by age, the usage of telephone follow-up for men in their 50s or younger was particularly low. Additionally, the interval between face-to-face visits increased in patients over 60 years-of-age.CONCLUSIONSThe telephone follow-up among patients with urologic malignancies in Japan increased significantly during the early phase of the COVID-19 pandemic. Our results indicate that telephone follow-up can potentially be a valuable patient-doctor communication tool. | 
    
|---|---|
| AbstractList | BACKGROUNDThis study aimed to compare telephone follow-ups for patients with urologic malignancies in Japan before and during the COVID-19 pandemic.METHODSUsing the database of the Japan Medical Data Center Co., Ltd., we identified patients with urologic malignancies who underwent at least one telephone follow-up between April 2014 and March 2020.The self-controlled case series method was used to calculate the incidence rate ratio of telephone follow-up utilization for the pandemic using the pre-pandemic period as a reference.RESULTSOf the 289 patients, 31 were women. Their median age was 80 years, and the median observation period was 28 months.The incidence rate ratio for telephone follow-up utilization during the pandemic was 17.8 compared to that of the pre-pandemic period. In an analysis stratified by type of carcinoma, the incidence rate ratios were higher in all strata than they were before the pandemic. However, among male patients with genital malignancies, particularly prostate cancers, the incidence rate ratio was lower than in other strata.According to analysis stratified by age, the usage of telephone follow-up for men in their 50s or younger was particularly low. Additionally, the interval between face-to-face visits increased in patients over 60 years-of-age.CONCLUSIONSThe telephone follow-up among patients with urologic malignancies in Japan increased significantly during the early phase of the COVID-19 pandemic. Our results indicate that telephone follow-up can potentially be a valuable patient-doctor communication tool. This study aimed to compare telephone follow-ups for patients with urologic malignancies in Japan before and during the COVID-19 pandemic.BACKGROUNDThis study aimed to compare telephone follow-ups for patients with urologic malignancies in Japan before and during the COVID-19 pandemic.Using the database of the Japan Medical Data Center Co., Ltd., we identified patients with urologic malignancies who underwent at least one telephone follow-up between April 2014 and March 2020.The self-controlled case series method was used to calculate the incidence rate ratio of telephone follow-up utilization for the pandemic using the pre-pandemic period as a reference.METHODSUsing the database of the Japan Medical Data Center Co., Ltd., we identified patients with urologic malignancies who underwent at least one telephone follow-up between April 2014 and March 2020.The self-controlled case series method was used to calculate the incidence rate ratio of telephone follow-up utilization for the pandemic using the pre-pandemic period as a reference.Of the 289 patients, 31 were women. Their median age was 80 years, and the median observation period was 28 months.The incidence rate ratio for telephone follow-up utilization during the pandemic was 17.8 compared to that of the pre-pandemic period. In an analysis stratified by type of carcinoma, the incidence rate ratios were higher in all strata than they were before the pandemic. However, among male patients with genital malignancies, particularly prostate cancers, the incidence rate ratio was lower than in other strata.According to analysis stratified by age, the usage of telephone follow-up for men in their 50s or younger was particularly low. Additionally, the interval between face-to-face visits increased in patients over 60 years-of-age.RESULTSOf the 289 patients, 31 were women. Their median age was 80 years, and the median observation period was 28 months.The incidence rate ratio for telephone follow-up utilization during the pandemic was 17.8 compared to that of the pre-pandemic period. In an analysis stratified by type of carcinoma, the incidence rate ratios were higher in all strata than they were before the pandemic. However, among male patients with genital malignancies, particularly prostate cancers, the incidence rate ratio was lower than in other strata.According to analysis stratified by age, the usage of telephone follow-up for men in their 50s or younger was particularly low. Additionally, the interval between face-to-face visits increased in patients over 60 years-of-age.The telephone follow-up among patients with urologic malignancies in Japan increased significantly during the early phase of the COVID-19 pandemic. Our results indicate that telephone follow-up can potentially be a valuable patient-doctor communication tool.CONCLUSIONSThe telephone follow-up among patients with urologic malignancies in Japan increased significantly during the early phase of the COVID-19 pandemic. Our results indicate that telephone follow-up can potentially be a valuable patient-doctor communication tool. This study aimed to compare telephone follow-ups for patients with urologic malignancies in Japan before and during the COVID-19 pandemic. Using the database of the Japan Medical Data Center Co., Ltd., we identified patients with urologic malignancies who underwent at least one telephone follow-up between April 2014 and March 2020.The self-controlled case series method was used to calculate the incidence rate ratio of telephone follow-up utilization for the pandemic using the pre-pandemic period as a reference. Of the 289 patients, 31 were women. Their median age was 80 years, and the median observation period was 28 months.The incidence rate ratio for telephone follow-up utilization during the pandemic was 17.8 compared to that of the pre-pandemic period. In an analysis stratified by type of carcinoma, the incidence rate ratios were higher in all strata than they were before the pandemic. However, among male patients with genital malignancies, particularly prostate cancers, the incidence rate ratio was lower than in other strata.According to analysis stratified by age, the usage of telephone follow-up for men in their 50s or younger was particularly low. Additionally, the interval between face-to-face visits increased in patients over 60 years-of-age. The telephone follow-up among patients with urologic malignancies in Japan increased significantly during the early phase of the COVID-19 pandemic. Our results indicate that telephone follow-up can potentially be a valuable patient-doctor communication tool.  | 
    
| ArticleNumber | 25010 | 
    
| Author | Shiro Hinotsu Naoya Masumori Keiko Fujino  | 
    
| Author_xml | – sequence: 1 givenname: Keiko surname: Fujino fullname: Fujino, Keiko – sequence: 2 givenname: Naoya surname: Masumori fullname: Masumori, Naoya – sequence: 3 givenname: Shiro surname: Hinotsu fullname: Hinotsu, Shiro  | 
    
| BackLink | https://cir.nii.ac.jp/crid/1390303167207506048$$DView record in CiNii https://www.ncbi.nlm.nih.gov/pubmed/40697796$$D View this record in MEDLINE/PubMed  | 
    
| BookMark | eNp9kUtv1DAUhS1UREvphh-AvGCBQCl-JHG8QAiNKA8VwaKzRNYd907iymOHOGHUf49JylA2LPyQfe53ro8fk6MQAxLylLNzqZRUr8HiuagYZw_IiShlWZRSNkf39sfkLKUbxphQijNdPSLHJau1Uro-Id9XHYQWE3WBjh3SdUIat_QKPfZddqIX0fu4L6Y-UdjF0NJvMDoMY6J7N3Z0PUQfW2fpF_CuDRCsW2CfoYfwhDzcgk94dreekvXF-6vVx-Ly64dPq3eXhZVSsEJYKK0s-WYrmqbSHGp1zWXVaG1rhdLqquZWyI0WslJlw1nDG8a3ItdWmmElT8mrhTuFHm734L3pB7eD4dZwZuacTM7JzDll9dtF3U-bHV7b_JoB_lZEcObfm-A608afhguhdM4uE17cEYb4Y8I0mp1LFr2HgHFKRubWykbnkaXP7psdXP58QRa8XAR2iCkNuP1_688XcXDOWPd75lIzySSvlWCqYjWbTd8ssps0QosHIgyjsx5noDIyjxl7OLcdDAaD_AW4wbX7 | 
    
| Cites_doi | 10.1002/sim.2302 10.1177/1357633X17732801 10.1016/j.eururo.2020.04.055 10.2196/14250 10.1089/tmj.2019.0065 10.21037/mhealth.2018.09.08 10.1001/jamahealthforum.2020.0734 10.1016/j.urology.2020.04.004 10.1016/j.eururo.2022.03.029 10.2196/27982 10.1016/S1470-2045(20)30217-5 10.1201/9780429491313  | 
    
| ContentType | Journal Article | 
    
| Copyright | 2025 Society for Clinical Epidemiology 2025 Society for Clinical Epidemiology. 2025 Society for Clinical Epidemiology 2025 Society for Clinical Epidemiology  | 
    
| Copyright_xml | – notice: 2025 Society for Clinical Epidemiology – notice: 2025 Society for Clinical Epidemiology. – notice: 2025 Society for Clinical Epidemiology 2025 Society for Clinical Epidemiology  | 
    
| DBID | RYH AAYXX CITATION NPM 7X8 5PM ADTOC UNPAY  | 
    
| DOI | 10.37737/ace.25010 | 
    
| DatabaseName | CiNii Complete CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall  | 
    
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic  | 
    
| DatabaseTitleList | MEDLINE - Academic PubMed  | 
    
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository  | 
    
| DeliveryMethod | fulltext_linktorsrc | 
    
| Discipline | Medicine | 
    
| DocumentTitleAlternate | TELEMEDICINE FOR UROLOGIC CANCER DURING COVID-19 IN JAPAN | 
    
| EISSN | 2434-4338 | 
    
| EndPage | 89 | 
    
| ExternalDocumentID | 10.37737/ace.25010 PMC12279406 40697796 10_37737_ace_25010 article_ace_7_3_7_25010_article_char_en  | 
    
| Genre | Journal Article | 
    
| GroupedDBID | ALMA_UNASSIGNED_HOLDINGS GROUPED_DOAJ JSF JSH M~E OK1 PGMZT RJT RPM RZJ RYH AAYXX CITATION NPM 7X8 5PM ADTOC UNPAY  | 
    
| ID | FETCH-LOGICAL-c3320-2ca4c341bf288591a67d135899c67e3c9561c23b92357481081801f2320590e53 | 
    
| IEDL.DBID | UNPAY | 
    
| ISSN | 2434-4338 | 
    
| IngestDate | Sun Oct 26 03:38:51 EDT 2025 Thu Aug 21 18:25:25 EDT 2025 Thu Jul 24 01:49:58 EDT 2025 Sat Jul 26 01:47:28 EDT 2025 Wed Oct 01 05:53:06 EDT 2025 Thu Jun 26 23:50:27 EDT 2025 Wed Sep 03 06:30:47 EDT 2025  | 
    
| IsDoiOpenAccess | true | 
    
| IsOpenAccess | true | 
    
| IsPeerReviewed | true | 
    
| IsScholarly | true | 
    
| Issue | 3 | 
    
| Keywords | COVID-19 telemedicine self-controlled case series method urologic malignancies telephone follow-up  | 
    
| Language | English | 
    
| License | https://creativecommons.org/licenses/by-nc-nd/4.0 2025 Society for Clinical Epidemiology. This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license. cc-by-nc-nd  | 
    
| LinkModel | DirectLink | 
    
| MergedId | FETCHMERGED-LOGICAL-c3320-2ca4c341bf288591a67d135899c67e3c9561c23b92357481081801f2320590e53 | 
    
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23  | 
    
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://doi.org/10.37737/ace.25010 | 
    
| PMID | 40697796 | 
    
| PQID | 3232489248 | 
    
| PQPubID | 23479 | 
    
| PageCount | 10 | 
    
| ParticipantIDs | unpaywall_primary_10_37737_ace_25010 pubmedcentral_primary_oai_pubmedcentral_nih_gov_12279406 proquest_miscellaneous_3232489248 pubmed_primary_40697796 crossref_primary_10_37737_ace_25010 nii_cinii_1390303167207506048 jstage_primary_article_ace_7_3_7_25010_article_char_en  | 
    
| ProviderPackageCode | CITATION AAYXX  | 
    
| PublicationCentury | 2000 | 
    
| PublicationDate | 2025-Jul-01 | 
    
| PublicationDateYYYYMMDD | 2025-07-01 | 
    
| PublicationDate_xml | – month: 07 year: 2025 text: 2025-Jul-01 day: 01  | 
    
| PublicationDecade | 2020 | 
    
| PublicationPlace | Japan | 
    
| PublicationPlace_xml | – name: Japan | 
    
| PublicationTitle | Annals of Clinical Epidemiology | 
    
| PublicationTitleAlternate | Ann Clin Epidemiol | 
    
| PublicationTitle_FL | Annals of Clinical Epidemiology Ann Clin Epidemiol ACE  | 
    
| PublicationYear | 2025 | 
    
| Publisher | Society for Clinical Epidemiology 一般社団法人 日本臨床疫学会  | 
    
| Publisher_xml | – name: Society for Clinical Epidemiology – name: 一般社団法人 日本臨床疫学会  | 
    
| References | 1. Centers for Medicare & Medicaid Services. COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers., Available from: https://www.cms.gov/files/document/covid-19-emergency-declaration-waivers.pdf, Accessed 2020 June 5. 7. Japan Medical Data Center. Available from: https://www.jmdc.co.jp/en/, Accessed 2024 April 2. 16. Nouri SS, Avila-Garcia P, Cemballi AG, et al. Assessing Mobile Phone Digital Literacy and Engagement in User-Centered Design in a Diverse, Safety-Net Population: Mixed Methods study. JMIR Mhealth Uhealth. 2019;7:e14250. 17. Miyawaki A, Tabuchi T, Ong MK, et al. Age and Social Disparities in the Use of Telemedicine During the COVID-19 Pandemic in Japan: Cross-sectional Study. J Med Internet Res. 2021;23:e27982. 10. Centers for Medicare & Medicaid Services, Medicare Telemedicine Snapshot. Available from: https://www.cms.gov/files/document/medicare-telemedicine-snapshot.pdf, Accessed 2022 September 25. 3. Luciani LG, Mattevi D, Cai T, et al. Teleurology in the Time of Covid-19 Pandemic: Here to Stay? Urology. 2020;140:4–6. 4. Burki TK. Cancer guidelines during the COVID-19 pandemic. Lancet Oncol. 2020;21:629–630. 11. Agochukwu NQ, Skolarus TA, Wittmann D. Telemedicine and prostate cancer survivorship: a narrative review. MHealth. 2018;4:45. 2. Ministry of Health, Labour and Welfare, Temporary and exceptional handling of medical treatment using telephones and telecommunications equipment, etc. during the spread of new coronavirus infection (in Japanese)., Available from: https://www.mhlw.go.jp/content/000620995.pdf, Accessed 2020 June 2. 5. Boehm K, Ziewers S, Brandt MP, et al. Telemedicine Online Visits in Urology During the COVID-19 Pandemic-Potential, Risk Factors, and Patients’ Perspective. Eur Urol. 2020;78:16–20. 13. Ito J, Edirippulige S, Aono T, et al. The use of telemedicine for delivering healthcare in Japan: Systematic review of literature published in Japanese and English languages. J Telemed Telecare. 2017;23:828–834. 6. Japan Telemedicine and Telecare Association, Telemedicine in Japan 2023. Available from: http://jtta.umin.jp/pdf/telemedicine/telemedicine_in_japan_20131015-2_en.pdf, Accessed 2024 April 2. 9. Farrington P, Whitaker H, Weldeselassie YG. Self-Controlled Case Series Studies: A Modelling Guide with R. 2018, Chapman & Hall/CRC Press, New York. 8. Whitaker HJ, Farrington CP, Spiessens B, et al. Tutorial in biostatistics: the self-controlled case series method. Stat Med. 2006;25:1768–1797. 12. Turco F, Armstrong A, Attard G, et al. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. Eur Urol. 2022;82:6–11. 15. Walker DM, Hefner JL, Fareed N, et al. Exploring the Digital Divide: Age and Race Disparities in Use of an Inpatient Portal. Telemed J E Health. 2020;25:603–613. 14. Gray DM 2nd, Joseph JJ, Olayiwola JN. Strategies for Digital Care of Vulnerable Patients in a COVID-19 World—Keeping in Touch. JAMA Health Forum. 2020;1:e200734. 11 12 13 14 15 16 17 1 2 3 4 5 6 7 8 9 10  | 
    
| References_xml | – reference: 12. Turco F, Armstrong A, Attard G, et al. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. Eur Urol. 2022;82:6–11. – reference: 6. Japan Telemedicine and Telecare Association, Telemedicine in Japan 2023. Available from: http://jtta.umin.jp/pdf/telemedicine/telemedicine_in_japan_20131015-2_en.pdf, Accessed 2024 April 2. – reference: 11. Agochukwu NQ, Skolarus TA, Wittmann D. Telemedicine and prostate cancer survivorship: a narrative review. MHealth. 2018;4:45. – reference: 13. Ito J, Edirippulige S, Aono T, et al. The use of telemedicine for delivering healthcare in Japan: Systematic review of literature published in Japanese and English languages. J Telemed Telecare. 2017;23:828–834. – reference: 4. Burki TK. Cancer guidelines during the COVID-19 pandemic. Lancet Oncol. 2020;21:629–630. – reference: 15. Walker DM, Hefner JL, Fareed N, et al. Exploring the Digital Divide: Age and Race Disparities in Use of an Inpatient Portal. Telemed J E Health. 2020;25:603–613. – reference: 1. Centers for Medicare & Medicaid Services. COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers., Available from: https://www.cms.gov/files/document/covid-19-emergency-declaration-waivers.pdf, Accessed 2020 June 5. – reference: 14. Gray DM 2nd, Joseph JJ, Olayiwola JN. Strategies for Digital Care of Vulnerable Patients in a COVID-19 World—Keeping in Touch. JAMA Health Forum. 2020;1:e200734. – reference: 2. Ministry of Health, Labour and Welfare, Temporary and exceptional handling of medical treatment using telephones and telecommunications equipment, etc. during the spread of new coronavirus infection (in Japanese)., Available from: https://www.mhlw.go.jp/content/000620995.pdf, Accessed 2020 June 2. – reference: 3. Luciani LG, Mattevi D, Cai T, et al. Teleurology in the Time of Covid-19 Pandemic: Here to Stay? Urology. 2020;140:4–6. – reference: 7. Japan Medical Data Center. Available from: https://www.jmdc.co.jp/en/, Accessed 2024 April 2. – reference: 10. Centers for Medicare & Medicaid Services, Medicare Telemedicine Snapshot. Available from: https://www.cms.gov/files/document/medicare-telemedicine-snapshot.pdf, Accessed 2022 September 25. – reference: 9. Farrington P, Whitaker H, Weldeselassie YG. Self-Controlled Case Series Studies: A Modelling Guide with R. 2018, Chapman & Hall/CRC Press, New York. – reference: 16. Nouri SS, Avila-Garcia P, Cemballi AG, et al. Assessing Mobile Phone Digital Literacy and Engagement in User-Centered Design in a Diverse, Safety-Net Population: Mixed Methods study. JMIR Mhealth Uhealth. 2019;7:e14250. – reference: 8. Whitaker HJ, Farrington CP, Spiessens B, et al. Tutorial in biostatistics: the self-controlled case series method. Stat Med. 2006;25:1768–1797. – reference: 17. Miyawaki A, Tabuchi T, Ong MK, et al. Age and Social Disparities in the Use of Telemedicine During the COVID-19 Pandemic in Japan: Cross-sectional Study. J Med Internet Res. 2021;23:e27982. – reference: 5. Boehm K, Ziewers S, Brandt MP, et al. Telemedicine Online Visits in Urology During the COVID-19 Pandemic-Potential, Risk Factors, and Patients’ Perspective. Eur Urol. 2020;78:16–20. – ident: 2 – ident: 8 doi: 10.1002/sim.2302 – ident: 13 doi: 10.1177/1357633X17732801 – ident: 5 doi: 10.1016/j.eururo.2020.04.055 – ident: 16 doi: 10.2196/14250 – ident: 15 doi: 10.1089/tmj.2019.0065 – ident: 1 – ident: 11 doi: 10.21037/mhealth.2018.09.08 – ident: 14 doi: 10.1001/jamahealthforum.2020.0734 – ident: 3 doi: 10.1016/j.urology.2020.04.004 – ident: 10 – ident: 12 doi: 10.1016/j.eururo.2022.03.029 – ident: 17 doi: 10.2196/27982 – ident: 6 – ident: 4 doi: 10.1016/S1470-2045(20)30217-5 – ident: 7 – ident: 9 doi: 10.1201/9780429491313  | 
    
| SSID | ssj0002771095 | 
    
| Score | 2.2986083 | 
    
| Snippet | BACKGROUNDThis study aimed to compare telephone follow-ups for patients with urologic malignancies in Japan before and during the COVID-19... BackgroundThis study aimed to compare telephone follow-ups for patients with urologic malignancies in Japan before and during the COVID-19... This study aimed to compare telephone follow-ups for patients with urologic malignancies in Japan before and during the COVID-19 pandemic. Using the database... This study aimed to compare telephone follow-ups for patients with urologic malignancies in Japan before and during the COVID-19 pandemic.BACKGROUNDThis study...  | 
    
| SourceID | unpaywall pubmedcentral proquest pubmed crossref nii jstage  | 
    
| SourceType | Open Access Repository Aggregation Database Index Database Publisher  | 
    
| StartPage | 80 | 
    
| SubjectTerms | COVID-19 Original self-controlled case series method telemedicine telephone follow-up urologic malignancies  | 
    
| Title | Changes in the Use of Telephone Follow-ups among Patients with Urologic Malignancies in Japan | 
    
| URI | https://www.jstage.jst.go.jp/article/ace/7/3/7_25010/_article/-char/en https://cir.nii.ac.jp/crid/1390303167207506048 https://www.ncbi.nlm.nih.gov/pubmed/40697796 https://www.proquest.com/docview/3232489248 https://pubmed.ncbi.nlm.nih.gov/PMC12279406 https://doi.org/10.37737/ace.25010  | 
    
| UnpaywallVersion | publishedVersion | 
    
| Volume | 7 | 
    
| hasFullText | 1 | 
    
| inHoldings | 1 | 
    
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Annals of Clinical Epidemiology, 2025/07/01, Vol.7(3), pp.80-89 | 
    
| journalDatabaseRights | – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources (ISSN International Center) customDbUrl: eissn: 2434-4338 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0002771095 issn: 2434-4338 databaseCode: M~E dateStart: 20190101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2434-4338 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0002771095 issn: 2434-4338 databaseCode: RPM dateStart: 20210101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine  | 
    
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fT9swED6xMm287PePsIG8jdd0JHZj5xGhVQipiAcisYcpsl2HdUNpRRqh8ddzZ6cRZRPaQ_PQXtLkfPZ9F_v7DLA3FcKozOi4Sh2Jajsb50LksUkql2Lxlu9bIgpPTrKjQhyfj8434POKC3Nn_p5LyeVXbd0Q0zSxqDazEeLtAWwWJ6cH32nXOMEFUX5U0B29d8Japnn8C8EWsegf1bPZv9Dk34sin7b1Qv-51peXdzLO-Dkcru41LDT5PWyXZmhv7sk4PvwwL-BZBzjZQYiQl7Dh6lfwZNJNqb-GH4Ff0LBZzRAMsqJxbF6xM0xHtGzdsTFGyvw6bhcN8zsTsdMgxdoweofLiqswfLIJIvqLsNmvv9gxpuH6DRTjb2eHR3G350JsOZGpU6uFxcxmqlSRtJ3O5DThI6zKbCYdt8SDtSk3OcnkCJWQIt5-UiEuIxarG_G3MKjx5t4DkxLLo2meVMoJ4ZzIbc4z9IPSJndamQi-rNqnXARpjRJLEu-pEj1Vek9FkIWm6226LuVNZMnx4w3774muhn0-gh1s6hJ9iUfEuTiaEes_JYyU4bgVwadVEJTYpWieRNdu3jYlJ5SpsDBFm3chKPo_J6KwlHkWgVoLl96A5LrXf6lnP71sd0JijXh-BHt9ZD3w4Nv_Z_YBtlLaktivIP4Ig-VV63YQJy3Nrn91tdt1l1t9jw3v | 
    
| linkProvider | Unpaywall | 
    
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9NAEB6VFFEuPFswpWiBXp3W3s0-jlVFVFVK1UMtlQOy1ps1BConqmNV8OuZ8TpWU6qKQ3xIxq_Z2Z1vsvt9C7A_FaLQsrBxmXoS1fYuNkKYuEhKn2LxZg4dEYUnZ_IkE6eXo8sN-LTiwtyav-dKcXVgnR9imiYW1aYcId4ewGZ2dn70lXaNE1wQ5UcH3dE7J6xlmsc_EWwRi_5RNZvdhyb_XRS51VQL-_vGXl3dyjjj53C8etaw0OTXsFkWQ_fnjozjwy_zAp51gJMdhQh5CRu-egVPJt2U-mv4FvgFNZtVDMEgy2rP5iW7wHREy9Y9G2OkzG_iZlGzdmcidh6kWGtG_-Gy7DoMn2yCiP572Oy3vdgppuFqG7Lxl4vjk7jbcyF2nMjUqbPCYWYrylSTtJ2VaprwEVZlTirPHfFgXcoLQzI5QiekiHeYlIjLiMXqR3wHBhU-3FtgSmF5NDVJqb0Q3gvjDJfoB20L460uIvi8ap98EaQ1cixJWk_l6Km89VQEMjRdb9N1qdZE5Rw_rWH_PdHVsM9HsIdNnaMv8Yg4F0czYv2nhJEkjlsRfFwFQY5diuZJbOXnTZ1zQpkaC1O0eROCor85EYWVMjICvRYuvQHJda__Us1-tLLdCYk14vkR7PeR9cCLv_s_s114mtKWxO0K4vcwWF43fg9x0rL40HWUvy9SDN8 | 
    
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Changes+in+the+Use+of+Telephone+Follow-ups+among+Patients+with+Urologic+Malignancies+in+Japan&rft.jtitle=Annals+of+clinical+epidemiology&rft.au=Fujino%2C+Keiko&rft.au=Masumori%2C+Naoya&rft.au=Hinotsu%2C+Shiro&rft.date=2025-07-01&rft.eissn=2434-4338&rft.volume=7&rft.issue=3&rft.spage=80&rft_id=info:doi/10.37737%2Face.25010&rft_id=info%3Apmid%2F40697796&rft.externalDocID=40697796 | 
    
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2434-4338&client=summon | 
    
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2434-4338&client=summon | 
    
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2434-4338&client=summon |